Updates are available Correction dated 2025-06-09
Click to view Correction: https://doi.org/10.1038/s41588-025-02251-w
-
Authors
Skerget, Sheri
Penaherrera, Daniel
Chari, Ajai https://orcid.org/0000-0002-0405-7480
Jagannath, Sundar https://orcid.org/0000-0003-2934-6518
Siegel, David S. https://orcid.org/0000-0002-3604-2574
Vij, Ravi
Orloff, Gregory
Jakubowiak, Andrzej
Niesvizky, Ruben
Liles, Darla https://orcid.org/0000-0003-1480-7887
Berdeja, Jesus https://orcid.org/0000-0003-4362-0376
Levy, Moshe
Wolf, Jeffrey
Usmani, Saad Z. https://orcid.org/0000-0002-5484-8731
,
Rifkin, Robert
Meehan, Kenneth
Benson, Don
Zonder, Jeffrey
Ascensao, Joao
Gasparetto, Cristina
Hernández, Miguel
Trudel, Suzanne
Dakhil, Shaker
Bahlis, Nizar
Paganini, Juan Vazquez
Rios, Pablo
Sampol, Antonia
Mannem, Siva
Silbermann, Rebecca
Lunning, Matthew
Chu, Michael
Milner, Carter
Harroff, Allyson
Graham, Mark
Shao, Spencer
Dodlapati, Jyothi
de Larrea, Carlos Fernández
Klein, Leonard
Kuzma, Charles
Fonseca, Rafael
Azaceta, Gemma
Granell, Miquel
Martinez-Chamorro, Carmen
Balaraman, Rama
Silva, Carlos
Chinea, Anabelle
Costello, Caitlin
Kambhampati, Suman
Lewis, DeQuincy
Grossbard, Michael
Yost, Kathleen
Robles, Robert
Sebag, Michael
Harris, Wayne
Ngaiza, Justinian
Bar, Michael
Shieh, Marie
Min, Fredrick
Onitilo, Adedayo
Volterra, Fabio
Wachsman, William
Yalamachili, Madhuri
Abella, Eugenia
Anderson, Larry
Bargay, Joan
Hassoun, Hani
Hsu, Gerald
Kaya, Hakan
Menter, Alex
Patel, Dilip
Richards, Donald
Solomon, William
Anderson, Robert
Chandra, Sumeet
Conde, Miguel
Girnius, Saulias
Matkiwsky, May
Krsnik, Isabel
Kumar, Shaji
Oriol, Albert
Rodríguez, Paula
Roy, Vivek
Srinivas, Shanti
Steis, Ronald
Christofferson, Austin W.
Nasser, Sara
Aldrich, Jessica L.
Legendre, Christophe
Benard, Brooks https://orcid.org/0000-0001-7154-744X
Miller, Chase
Turner, Bryce
Kurdoglu, Ahmet
Washington, Megan
Yellapantula, Venkata https://orcid.org/0000-0003-1592-7741
Adkins, Jonathan R.
Cuyugan, Lori
Boateng, Martin
Helland, Adrienne
Kyman, Shari https://orcid.org/0000-0001-5386-5866
McDonald, Jackie
Reiman, Rebecca
Stephenson, Kristi
Tassone, Erica
Blanski, Alex
Livermore, Brianne
Kirchhoff, Meghan
Rohrer, Daniel C. https://orcid.org/0000-0002-1784-9196
D’Agostino, Mattia
Gambella, Manuela
Collison, Kimberly
Stumph, Jennifer https://orcid.org/0000-0003-2423-0241
Kidd, Pam
Donnelly, Andrea
Zaugg, Barbara
Toone, Maureen
McBride, Kyle
DeRome, Mary
Rogers, Jennifer
Craig, David
Liang, Winnie S. https://orcid.org/0000-0002-5698-7735
Gutierrez, Norma C. https://orcid.org/0000-0001-5834-9510
Jewell, Scott D. https://orcid.org/0000-0001-9469-6261
Carpten, John
Anderson, Kenneth C. https://orcid.org/0000-0002-6418-0886
Cho, Hearn Jay
Auclair, Daniel https://orcid.org/0000-0001-5151-3058
Lonial, Sagar
Keats, Jonathan J. https://orcid.org/0000-0003-4375-7399
-
Funding
Funding for this research was provided by:
Multiple Myeloma Research Foundation (CoMMpass Study)
- License Information
-
More Information
Article History
Received: 9 July 2021
Accepted: 28 June 2024
First Online: 19 August 2024
Change Date: 9 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41588-025-02251-w
Competing interests
: S.S. is currently employed by Janssen. A.C. has received research funding from Amgen, BMS, Janssen, Seattle Genetics and Takeda, and is a speaker/consultant/advisory board member for Abbvie, Amgen, Antengene, BMS, Genentech, GSK, Janssen, Karyopharm, Sanofi, Seattle Genetics, Secura Bio, Shattuck Labs and Takeda. S.J. is a speaker/consultant/advisory board member for BMS, Caribou Biosciences, DMC, Janssen, Regeneron, Sanofi and Takeda. D.S.S. has received research funding from Amgen, BMS, Janssen, Karyopharm, Novartis and Takeda, and is a speaker/consultant/advisory board member for Amgen, BMS, Celularity Scientific, Janssen, Karyopharm, Novartis and Takeda. R.V. has received research funding from BMS, Sanofi and Takeda, and is a speaker/consultant/advisory board member for BMS, Harpoon, Janssen Karyopharm, Legend Biotech, Pfizer, Sanofi and Takeda. A.J. is a speaker/consultant/advisory board member for Abbvie, BMS, Amgen, GSK, Janssen and Sanofi. R.N. has received research funding from BMS, GSK, Janssen, Karyopharm, Pfizer, Regeneron and Takeda, and is a speaker/consultant/advisory board member for BMS, GSK, Janssen, Karyopharm, Pfizer, Regeneron, Sanofi and Takeda. D.L. has received research funding from Annexon Biosciences, Alpine Immune, Abbvie, Astex Pharmaceuticals, Baxalta, BeiGene, Bioverativ, CSL Behring, BMS, Delta-Fly Pharma, Exact Sciences, Forma Therapeutics, Global Blood Therapeutics, Immunovant, Incycte, Janssen, NeoImmuneTech, Novartis, Novo Nordisk, Partner Therapeutics, Pharm-Olam, Principia Biopharma, Salix Pharmaceuticals, Sanofi, Takeda and Vifor Pharma. J.B. has received research funding from AbbVie, Acetylon, Amgen, BMS, C4 Therapeutics, CARSgen, Cartesian, Celularity, CRISPR Therapeutics, EMD Serono, Fate Therapeutics, Genentech, GSK, Ichnos Sciences, Incyte, Janssen, Karyopharm, Lilly, Novartis, Poseida, Sanofi, Takeda, Teva and 2seventy bio, and is a speaker/consultant/advisory board member for BMS, CRISPR Therapeutics, Janssen, Kite Pharma, Legend Biotech, Roche and Takeda. M.L. is a speaker/consultant/advisory board member for Abbvie, Amgen, AstraZeneca, BeiGene, BMS, Gilead, Genmab, Janssen, Jazz, Karyopharm, Morphosys, Novartis, Seagen, Sellas, Sobi, Sanofi and Takeda. S.Z.U. has received research funding from AbbVie, Amgen, Array Biopharma, BMS, EdoPharma, Gilead Sciences, GSK, Janssen, K36 Therapeutics, Merck, Moderna, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX and Takeda, and is a speaker/consultant/advisory board member for BMS, Genentech, Gilead Sciences, GSK, Janssen, Novartis, Oncopeptides, Sanofi, Seattle Genetics, Secura Bio, SkylineDX, Takeda and TeneoBio. M.D’A. has received research funding from Janssen and is a speaker/consultant/advisory board member for Adaptive Biotechnology, BMS, GSK, Janssen and Sanofi. M.D. is currently employed by the funder (MMRF). J.R. is currently employed by the funder (MMRF). K.C.A. is a speaker/consultant/advisory board member for Amgen, AstraZeneca, Daewoong, Dynamic Cell Therapies, Janssen, Pfizer, Mana Therapeutics, Oncopep, Precision Biosciences, Starton and Window Therapeutics, and is an equity holder in C4 Therapeutics, Dynamic Cell Therapies, NextRNA, Oncopep, Raqia, Starton and Window Therapeutics. H.J.C. is currently employed by the funder (MMRF) and has received research funding from BMS and Takeda. D.A. was previously employed by the funder (MMRF) and is currently employed by AstraZeneca. S.L. has received research funding from BMS, Janssen, Novartis and Takeda, and is a speaker/consultant/advisory board member for AbbVie, Amgen, BMS, Genentech, GSK, Janssen, Novartis, Pfizer, TG Therapeutics and Takeda. J.J.K. has received research funding from Amgen, Genentech and Janssen, and is a speaker/consultant/advisory board member for Janssen. The other authors declare no competing interests.
